Interferon beta-1b (Betaferon, BAY 86-5046)

DRUG2 trials

Sponsors

Bayer

Conditions

Multiple Sclerosis

Unknown Phase

Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on Betaferon

CompletedNCT01766063

BayerMultiple Sclerosis

Start: 2012-12-06End: 2017-03-14Updated: 2018-02-19

BAY86-5046 (Betaseron), Non Interventional Studies

CompletedNCT02121444

BayerMultiple Sclerosis

Start: 2014-06-23End: 2016-06-01Updated: 2017-10-18

Related Papers

Sleep quality, daytime sleepiness, fatigue, and quality of life in patients with multiple sclerosis treated with interferon beta-1b: results from a prospective observational cohort study.

2018-08-2440 citations

Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study.

2017-09-0613 citations